• Sara Rimer

    Senior Contributing Editor

    Sara Rimer

    Sara Rimer A journalist for more than three decades, Sara Rimer worked at the Miami Herald, Washington Post and, for 26 years, the New York Times, where she was the New England bureau chief, and a national reporter covering education, aging, immigration, and other social justice issues. Her stories on the death penalty’s inequities were nominated for a Pulitzer Prize and cited in the U.S. Supreme Court’s decision outlawing the execution of people with intellectual disabilities. Her journalism honors include Columbia University’s Meyer Berger award for in-depth human interest reporting. She holds a BA degree in American Studies from the University of Michigan. Profile

    She can be reached at srimer@bu.edu.

Comments & Discussion

Boston University moderates comments to facilitate an informed, substantive, civil conversation. Abusive, profane, self-promotional, misleading, incoherent or off-topic comments will be rejected. Moderators are staffed during regular business hours (EST) and can only accept comments written in English.

There are 4 comments on Battling Ebola: Working with a Deadly Virus

  1. Could you Please specify the climate that is well suited to EBOLA. Does it flourishes in tropical climate? Does living in cooler climate restrict this virus?

  2. Could you please further explain if the ebola virus could potentially reactivate similar to herpes simplex viruses? Herpes simplex will rarely kill a person, however Ebola is usually only compared to HIV or influenza. Are there long term side effects to being infected and surviving Ebola? I rarely find any information on anything regarding an ebola virus survivors quality of life.

  3. Hello there!! I have a question to be asked to all the research scientists who are working on this virus EBOLA for cure but could you just tell me how and where was this virus called EBOLA yielded first? And why we in this 21st century are unable find the cure? I hope the researches are going well and soon we’ll hear good news from all you.

  4. Ebola can be aerosolized. See p. 3 of PDF. https://www.mdpi.com/1999-4915/4/10/2115/pdf

    Also:

    http://www.cvr.pitt.edu/Personnel/view.asp?uid=dsreed

    Dr. Reed became a principal investigator at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) in 1999, developing animal models to aerosolized pathogens and conducting efficacy studies in those models. While at USAMRIID Dr. Reed conducted and supervised aerosol exposures of animals including rodents, rabbits, and nonhuman primates. Dr. Reed’s research at USAMRIID included developing nonhuman primate models of aerosol exposure to Venezuelan, Western, and Eastern Equine Encephalitis and evaluating candidate vaccines in those models, developing rodent and nonhuman primate models of aerosol exposure to Marburg and Ebola viruses, and evaluating a GMP-grade recombinant plague vaccine in mice against pneumonic plague. Dr. Reed is currently the Aerobiology Manager of the Regional Biocontainment Laboratory, working with collaborators to develop animal models of aerosol exposure to pathogens that are either biodefense threats or emerging infectious diseases.

Post a comment.

Your email address will not be published. Required fields are marked *